Angiology

Results: 1386



#Item
51The votes by Editorial BOARD (altogether 49 Top-Experts in predictive, preventive & personalised Medicine from 49 countries worldwide) have selected the best review-articles in the category “Predictive, Preventive & Pe

The votes by Editorial BOARD (altogether 49 Top-Experts in predictive, preventive & personalised Medicine from 49 countries worldwide) have selected the best review-articles in the category “Predictive, Preventive & Pe

Add to Reading List

Source URL: www.epmanet.eu

Language: English - Date: 2012-12-17 17:23:42
52Microsoft Word - setor_06_Cardiovascular_and_Renal.docx

Microsoft Word - setor_06_Cardiovascular_and_Renal.docx

Add to Reading List

Source URL: sbfte.org.br

Language: English - Date: 2015-04-06 13:16:05
53Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic mice

Add to Reading List

Source URL: www.cardiab.com

Language: English
54MINIPIGS A/S  Clean pigs for clear results GÖTTINGEN

MINIPIGS A/S Clean pigs for clear results GÖTTINGEN

Add to Reading List

Source URL: minipigs.dk

Language: English
55A-kursus i kar-radiologi: Ultralyd af arterier Jonas Eiberg Karkirugisk afdeling  “BASIC” vascular ultrasound

A-kursus i kar-radiologi: Ultralyd af arterier Jonas Eiberg Karkirugisk afdeling “BASIC” vascular ultrasound

Add to Reading List

Source URL: drs-uddannelse.dk

Language: English - Date: 2014-09-10 06:12:11
56Chapter 26: Page 255  In the last chapter,

Chapter 26: Page 255 In the last chapter,

Add to Reading List

Source URL: eequalsmcq.com

Language: English - Date: 2009-06-29 09:39:05
57FORM 10−K ENTREMED INC − ENMD Filed: March 16, 2005 (period: December 31, 2004) Annual report which provides a comprehensive overview of the company for the past year  Table of Contents

FORM 10−K ENTREMED INC − ENMD Filed: March 16, 2005 (period: December 31, 2004) Annual report which provides a comprehensive overview of the company for the past year Table of Contents

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2014-05-14 13:04:51
58MD Biomedical and Senzime presents results from the monitoring of oxygen depletion with Onzurf®and CliniSenzTM Uppsala, November 11, 2014. Senzime AB (publ) today announced results from a preclinical trial series in whi

MD Biomedical and Senzime presents results from the monitoring of oxygen depletion with Onzurf®and CliniSenzTM Uppsala, November 11, 2014. Senzime AB (publ) today announced results from a preclinical trial series in whi

Add to Reading List

Source URL: ubi.se

Language: English - Date: 2014-11-14 08:10:44
59Dear Valued Shareholder,						  April 2008 In 2007, EntreMed continued to make progress in advancing its clinical and preclinical development programs, securing additional funding, and strengthening our executive managem

Dear Valued Shareholder, April 2008 In 2007, EntreMed continued to make progress in advancing its clinical and preclinical development programs, securing additional funding, and strengthening our executive managem

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2014-05-14 13:04:22
60CMYK_Adobe_Illustrator.ai

CMYK_Adobe_Illustrator.ai

Add to Reading List

Source URL: www.vascularcell.com

Language: English